Ojie Anti-mutant citrulline waveform protein test group - Taiwan Registration 1e0ae49e30260b53413e196a6a793df4
Access comprehensive regulatory information for Ojie Anti-mutant citrulline waveform protein test group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 1e0ae49e30260b53413e196a6a793df4 and manufactured by ORGENTEC DIAGNOSTIKA GMBH. The authorized representative in Taiwan is IN FUNG CO., LTD..
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
The Anti-MCV Regimen is an indirect solid-phase enzyme immunoassay (ELISA) that quantifies the concentration of anti-mutant citrulline waveform protein (MCV) IgG autoantibodies in human serum or plasma. This test can only be used in vitro to help diagnose rheumatoid arthritis.
C Immunology and microbiology
C.5775 ้ก้ขจๆฟๆงๅ ๅญๅ ็ซ่ฉฆ้ฉ็ณป็ตฑ
import
Dates and Status
Nov 20, 2012
Nov 20, 2022
Apr 12, 2024
Cancellation Information
Logged out
่จฑๅฏ่ญๅทฒ้พๆๆๆ